| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/27/2008 | DE102006046411A1 Arzneimittel zur Prophylaxe oder Behandlung oder Diagnostik von akutem Lungenversagen (ALI) Drugs for the prophylaxis or treatment or diagnosis of acute lung injury (ALI) |
| 03/27/2008 | CA2663057A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 03/26/2008 | EP1903055A2 Recombinant haemophilus influenzae adhesin proteins |
| 03/26/2008 | EP1903044A1 Adenosine Derivatives as A2A Receptor Agonists |
| 03/26/2008 | EP1902710A1 Pharmaceutical composition and beverage composition comprising l-arginine |
| 03/26/2008 | EP1902314A1 Method for evaluating the effects of smoke on bronchioles |
| 03/26/2008 | EP1901776A1 Novel medicinal combinations which are used for treating respiratory tract diseases and contain beta-2 long-acting agonists and at least one other type of active substance |
| 03/26/2008 | EP1901751A1 Alpha-helix mimetics and methods relating to the treatment of fibrosis |
| 03/26/2008 | EP1901749A2 Aerosolized fluoroquinolones and uses thereof |
| 03/26/2008 | EP1901725A2 Use of pde1c and inhibitors thereof |
| 03/26/2008 | EP1716133B1 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors |
| 03/26/2008 | EP1573450A4 System and method for transparent early detection, warning, and intervention during a medical procedure |
| 03/26/2008 | EP1556342B1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 03/26/2008 | EP1509524B1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP1196396B1 Pharmacologically active compounds with two covalently linked active principles (sodium channnel blocker/p2y2 receptor agonist) for the treatment of mucosal surfaces |
| 03/26/2008 | CN101151239A Novel biaromatic compounds, inhibitors of the P2X7-receptor |
| 03/26/2008 | CN101147804A Anti Toll-like receptor 2 antibody anti pulmonary fibrosis use |
| 03/26/2008 | CN101147788A Medicine for treating cold and upper respiratory tract infection and its lung inflammation |
| 03/26/2008 | CN101147745A Artificial calculus bovis medicinal composition without smell of mutton, stench and bitter and preparation thereof |
| 03/26/2008 | CN101147732A Application of chlorogenic acid in preparing medicine with preventing and treating nasopharyngeal cancer function |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
| 03/26/2008 | CN100376571C 6-substituted pyrido-pyrimidines |
| 03/26/2008 | CN100376554C N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/26/2008 | CN100376250C Clamycin fast release micropill and its preparation method |
| 03/26/2008 | CN100376242C 2-aryl-propionic acid and medicine composition containing same |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348362 Bronchodilating β-agonist compositions and methods |
| 03/25/2008 | US7348360 Method and composition for delivering zinc to the nasal membrane |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348339 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348335 Compositions useful as inhibitors of JAK and other protein kinases |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | CA2419077C A method of treating a systemic disease |
| 03/25/2008 | CA2416867C Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |
| 03/25/2008 | CA2343123C Active substance concentrate with formoterol, suitable for storage |
| 03/25/2008 | CA2174707C Chromone derivatives as nk1 and substance p antagonists |
| 03/25/2008 | CA2164642C Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 03/20/2008 | WO2008034008A2 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/20/2008 | WO2008033999A2 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032696A1 Preventive or therapeutic agent for respiratory disease |
| 03/20/2008 | WO2008031875A1 Adenosine derivatives as a2a receptor agonists |
| 03/20/2008 | WO2008031438A2 Treatment of asthma, eczema and/or allergy using non-pathogenic organisms |
| 03/20/2008 | WO2008031437A2 Treatment of asthma, eczema and/or allergy using antibiotics |
| 03/20/2008 | WO2008031172A1 Methods and compositions for promoting organ development |
| 03/20/2008 | WO2007124447A3 Use of chalcogenides for treating shock and other adverse conditions |
| 03/20/2008 | WO2001025398A3 Process for inducing functional tolerance to gene transfer products |
| 03/20/2008 | US20080071069 For delivering DNA/RNA into cells |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070961 storage stability; precipitation |
| 03/20/2008 | US20080070946 Hydroxymethylbenzothiazoles Amides |
| 03/20/2008 | US20080070940 Side effect reduction of emesis; phosphodiesterase 4 (PDE4) inhibitor; 2-(3'-[3-[(cyclopropylamino)carbonyl)-4-oxo-1,8-naphthyridin-1(4H)-yl]-3-fluoro-1,1'-biphenyl-4-yl)cyclopropanecarboxylic acid, sodium salt; crystalline forms; allergies, autoimmune diseases, cancer, neurodegenerative disorders |
| 03/20/2008 | US20080070936 Compounds specific to adenosine A1 receptors and uses thereof |
| 03/20/2008 | US20080070909 Of amine salts of 1-(3-(2-(3-methanesulfonamino-4-hydroxyphenyl)-2-hydroxyethylamino)-3,3-dimethylpropyl)-1,2-dihydro-4H-3,1-benzoxazin-2-one betamimetics; physicochemical properties for use in inhalable form; treating respiratory system disorders |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | US20080070901 Cholineterase inhibitors for treating inflammation |
| 03/20/2008 | US20080070846 Treating acute exacerbations of asthma using a ketolide |
| 03/20/2008 | US20080070838 Growth Factor Treatment for Asthma |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080070258 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/20/2008 | US20080069913 Anti-Snoring Composition |
| 03/20/2008 | US20080069841 Pharmaceutical Compositions Containing Botulinum Neurotoxin A2 |
| 03/20/2008 | US20080069838 Novel human virus causing severe acute respiratory syndrome (sars) and uses thereof |
| 03/20/2008 | US20080066744 Process for producing metered dose inhaler formulations |
| 03/20/2008 | CA2663273A1 Methods and compositions for promoting organ development |
| 03/20/2008 | CA2662104A1 Adenosine derivatives as a2a receptor agonists |
| 03/19/2008 | EP1900753A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 03/19/2008 | EP1900739A1 Diazolodiazine derivatives as kinase inhibitors |
| 03/19/2008 | EP1900737A1 Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide |
| 03/19/2008 | EP1900728A1 Pharmaceutical composition comprising pyrazolone derivative |
| 03/19/2008 | EP1900373A1 Composition for treating asthma |
| 03/19/2008 | EP1899326A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 03/19/2008 | EP1899322A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 03/19/2008 | EP1899320A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM |
| 03/19/2008 | EP1899318A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 03/19/2008 | EP1898945A2 Airway administration of site-inactivated fviia in inflammatory conditions affecting the respiratory tract |
| 03/19/2008 | EP1898921A1 Compositions and methods for treating sleep disorders |
| 03/19/2008 | EP1898894A1 Mrp iv inhibitors for the treatment of respiratory diseases |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 03/19/2008 | EP1496876B1 Aerosol formulation for inhalation comprising tiotropiumbromide |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | EP1085877B1 Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma |
| 03/19/2008 | EP1019033B1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide |
| 03/19/2008 | EP0910647B1 Human dnase i hyperactive variants |
| 03/19/2008 | CN101146770A 2-phenyl-indoles as prostaglandin D2 receptor antagonists |
| 03/19/2008 | CN101146764A Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 03/19/2008 | CN101146545A Mucin hypersecretion inhibitors based on the structure of MANS and methods of use |
| 03/19/2008 | CN101143201A Medicine for treating chronic obstructive lung disease and its preparation method |